PRS and Twin Concordance for Schizophrenia and Bipolar Disorder
This case-control study investigates if genetic risk for bipolar disorder and schizophrenia (psychosis) is associated with twin concordance for these disorders.
This case-control study investigates if genetic risk for bipolar disorder and schizophrenia (psychosis) is associated with twin concordance for these disorders.
This cohort study examined the yield and use of genome sequencing after nondiagnostic exome sequencing for pediatric patients with unexplained epilepsy between August 2018 and…
This randomized clinical trial examines the effect of a benzodiazepine taper plus augmented cognitive behavioral therapy for insomnia program vs an unmasked taper plus standard…
This randomized clinical trial investigates the effect of a parent-administered screen time intervention in the hour before bed on objectively measured toddler sleep and attention.
Application Deadline: January 4, 2021. The Morris Fishbein Fellowship in Medical Editing is a unique one-year fellowship opportunity offered by JAMA to introduce physicians to…
This Medical News article discusses a new report from the National Academies of Sciences, Engineering, and Medicine on persistent gaps in women’s health research and…
This Viewpoint discusses the medical, ethical and legal conflicts clinicians face with the mandate to equally protect the health of the pregnant person and the…
PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.
PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.
This Viewpoint discusses factors that play a role in the low rate of lipid screening in children, including a lack of compelling evidence, disagreement with…
This cross-sectional study describes potential cost savings for both insured and uninsured users of brand-name inhalers in the US.